NSN 6505-01-251-1850 of Clorazepate Dipotas - Parts Details
| Alternative NSN: 6505012511850 |
| Item Name: Clorazepate Dipotas |
| FSG: 65 Medical Dental and Veterinary Equipment and Supplies |
| Federal Supply Class (FSC): 6505 Drugs and Biologicals |
| NIIN: 012511850 |
| NCB Code: USA (01) |
| Manufacturers: Taro Pharmaceuticals Usa Inc , Danbury Pharmacal Inc , Mylan Pharmaceuticals Inc , Actavis Inc , Abbott Laboratories Pharmaceutical Products Div |
ASAP Aviation Procurement, owned and operated by ASAP Semiconductor, is the latest parts procurement platform for the aerospace and aviation industry. Check out high demanding part numbers NDC51672-4043-02, NDC00591-0364-05, NDC00378-0040-05, NDC00228-3068-50, NDC00074-4390-53 under NSN 6505-01-251-1850 of Clorazepate Dipotas manufactured by Taro Pharmaceuticals Usa Inc, Danbury Pharmacal Inc, Mylan Pharmaceuticals Inc, Actavis Inc, Abbott Laboratories Pharmaceutical Products Div.
Federal Supply Class of NSN 6505-01-251-1850 is FSC 6505 contains part details of Drugs and Biologicals. Quote for your desired part numbers.
Part Number's List for NSN 6505-01-251-1850, 6505012511850
-
Part No Manufacturer Item Name QTY RFQ NDC51672-4043-02 Taro Pharmaceuticals Usa Inc clorazepate dipotas Avl RFQ NDC00591-0364-05 Danbury Pharmacal Inc clorazepate dipotas Avl RFQ NDC00378-0040-05 Mylan Pharmaceuticals Inc clorazepate dipotas Avl RFQ NDC00228-3068-50 Actavis Inc clorazepate dipotas Avl RFQ NDC00074-4390-53 Abbott Laboratories Pharmaceutical Products Div clorazepate dipotas Avl RFQ
Characteristics Data of NSN 6505012511850MRC Criteria Characteristic AKJA ACTIVE MEDICAMENT MEDICINAL STRENGTH 7.500 MILLIGRAMS CLORAZEPATE DIPOTASSIUM ACTIVE INGREDIENT CQCT PRIMARY CONTAINER TYPE BOTTLE CRLK PRIMARY CONTAINER CONTENT QUANTITY 500.000 TABLETS CXCY III PART NAME ASSIGNED BY CONTROLLING AGENCY CLORAZEPATE DIPOTASSIUM TABLETS USP 500S BT FEAT SPECIAL FEATURES SCHEDULE IV CONTROLLED SUBSTANCE CLASSIFICATION MDES MEDICAL DESIGNATION UNITED STATES PHARMACOPEIA
| MRC | Criteria | Characteristic |
|---|---|---|
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 7.500 MILLIGRAMS CLORAZEPATE DIPOTASSIUM ACTIVE INGREDIENT |
| CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 500.000 TABLETS |
| CXCY | III PART NAME ASSIGNED BY CONTROLLING AGENCY | CLORAZEPATE DIPOTASSIUM TABLETS USP 500S BT |
| FEAT | SPECIAL FEATURES | SCHEDULE IV CONTROLLED SUBSTANCE CLASSIFICATION |
| MDES | MEDICAL DESIGNATION | UNITED STATES PHARMACOPEIA |